Bridgeway Capital Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
|
|||||
|
2025
Q1 | $503K | Sell |
|
|||||
|
2024
Q4 | $731K | Sell |
|
|||||
|
2024
Q3 | $620K | Hold |
|
|||||
|
2024
Q2 | $553K | Buy |
|
|||||
|
2024
Q1 | $333K | Sell |
|
|||||
|
2023
Q4 | $283K | Buy |
|
|||||
|
2023
Q3 | $407K | Hold |
|
|||||
|
2023
Q2 | $446K | Sell |
|
|||||
|
2023
Q1 | $349K | Sell |
|
|||||
|
2022
Q4 | $402K | Buy |
|
|||||
|
2022
Q3 | $245K | Buy |
|
|||||
|
2022
Q2 | $288K | Buy |
|
|||||
|
2022
Q1 | $165K | Hold |
|
|||||
|
2021
Q4 | $59K | Buy |
|
|||||
|
2021
Q3 | $47K | Hold |
|
|||||
|
2021
Q2 | $78K | Sell |
|
|||||
|
2021
Q1 | $299K | Buy |
|
|||||
|
2020
Q4 | $242K | Hold |
|
|||||
|
2020
Q3 | $403K | Hold |
|
|||||
|
2020
Q2 | $658K | Buy |
|
|||||
|
2020
Q1 | $247K | Hold |
|
|||||
|
2019
Q4 | $281K | Buy |
|